Work

Minimal Residual Disease Eradication with Guadecitabine (SGI-110) in the Post-Transplant Setting

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-134204

Authors: Betul Oran, Amin M. Alousi, Rohtesh S. Mehta, David Marin, Partow Kebriaei, Uday R. Popat, Amanda L. Olson, Jessica M McCarty, Jennifer D Ramos, Roland Bassett, Harold N. Keer, Peter F Thall, Richard E. Champlin

Institutions: The University of Texas MD Anderson Cancer Center, Astex Pharmaceuticals

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097083801

FWCI:

Cites:

Cited by: 1

Related to: 10